• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于研究 HLA I 类抗原呈递的改良转基因小鼠模型。

Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation.

机构信息

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, 100101, China.

University of Chinese Academy of Sciences, Beijing, China.

出版信息

Sci Rep. 2016 Sep 16;6:33612. doi: 10.1038/srep33612.

DOI:10.1038/srep33612
PMID:27634283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5025652/
Abstract

HLA class I (HLA-I) transgenic mice have proven to be useful models for studying human MHC-related immune responses over the last two decades. However, differences in the processing and presentation machinery between humans and mice may have profound effects on HLA-I restricted antigen presentation. In this study, we generated a novel human TAP-LMP (hTAP-LMP) gene cluster transgenic mouse model carrying an intact human TAP complex and two human immunoproteasome LMP subunits, PSMB8/PSMB9. By crossing the hTAP-LMP strain with different HLA-I transgenic mice, we found that the expression levels of human HLA-I molecules, especially the A3 supertype members (e.g., A11 and A33), were remarkably enhanced in corresponding HLA-I/hTAP-LMP transgenic mice. Moreover, we found that humanized processing and presentation machinery increased antigen presentation of HLA-A11-restricted epitopes and promoted the rapid reduction of hepatitis B virus (HBV) infection in HLA-A11/hTAP-LMP mice. Together, our study highlights that HLA-I/hTAP-LMP mice are an improved model for studying antigen presentation of HLA-I molecules and their related CTL responses.

摘要

在过去的二十年中,HLA-I 类转基因小鼠已被证明是研究人类 MHC 相关免疫反应的有用模型。然而,人类和小鼠之间加工和呈递机制的差异可能对 HLA-I 类限制的抗原呈递产生深远的影响。在这项研究中,我们构建了一种新型的人 TAP-LMP(hTAP-LMP)基因簇转基因小鼠模型,该模型携带完整的人 TAP 复合物和两个人类免疫蛋白酶体 LMP 亚基 PSMB8/PSMB9。通过将 hTAP-LMP 株与不同的 HLA-I 转基因小鼠杂交,我们发现相应的 HLA-I/hTAP-LMP 转基因小鼠中人类 HLA-I 分子的表达水平,特别是 A3 超型成员(例如 A11 和 A33),显著增强。此外,我们发现,人源化的加工和呈递机制增加了 HLA-A11 限制性表位的抗原呈递,并促进了 HLA-A11/hTAP-LMP 小鼠中乙型肝炎病毒(HBV)感染的快速减少。总之,我们的研究强调了 HLA-I/hTAP-LMP 小鼠是研究 HLA-I 分子及其相关 CTL 反应的抗原呈递的改良模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/bf8e9a9423f4/srep33612-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/eda6b2b5e8c3/srep33612-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/ddf146f687bf/srep33612-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/85cea2254e1a/srep33612-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/bf8e9a9423f4/srep33612-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/eda6b2b5e8c3/srep33612-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/ddf146f687bf/srep33612-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/85cea2254e1a/srep33612-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeca/5025652/bf8e9a9423f4/srep33612-f4.jpg

相似文献

1
Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation.用于研究 HLA I 类抗原呈递的改良转基因小鼠模型。
Sci Rep. 2016 Sep 16;6:33612. doi: 10.1038/srep33612.
2
Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.利用MHC I类转基因小鼠开发编码多个HLA限制性CTL表位的小基因DNA疫苗。
J Immunol. 1999 Apr 1;162(7):3915-25.
3
Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.不变链作为一种载体,将抗原肽加载到人 MHC Ⅰ类分子上,用于细胞毒性 T 细胞的激活。
Eur J Immunol. 2014 Mar;44(3):774-84. doi: 10.1002/eji.201343671. Epub 2013 Dec 27.
4
Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.蛋白酶体抑制剂可恢复爱泼斯坦-巴尔病毒相关肿瘤中细胞毒性T细胞表位的呈递。
Int J Cancer. 2002 Oct 20;101(6):532-8. doi: 10.1002/ijc.10653.
5
Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.HLA-A11/Kb转基因小鼠的培育:功能性CTL库及对人A11限制性CTL表位的识别
J Immunol. 1997 Nov 15;159(10):4753-61.
6
Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.用于疫苗评估的人MHC(HLA - A11/DR1)转基因小鼠的培育
Hum Vaccin Immunother. 2016 Mar 3;12(3):829-36. doi: 10.1080/21645515.2015.1103405.
7
Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.通过定量质谱分析揭示的非TAP依赖性MHC I类配体的特征
Eur J Immunol. 2008 Jun;38(6):1503-10. doi: 10.1002/eji.200838136.
8
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.伯基特淋巴瘤细胞中MHC I类限制性细胞毒性T细胞表位呈递缺陷。
Int J Cancer. 1996 Oct 9;68(2):251-8. doi: 10.1002/(SICI)1097-0215(19961009)68:2<251::AID-IJC19>3.0.CO;2-D.
9
Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.致癌转化的小鼠成纤维细胞后MHC I类抗原加工机制的下调
Eur J Immunol. 1998 Jan;28(1):122-33. doi: 10.1002/(SICI)1521-4141(199801)28:01<122::AID-IMMU122>3.0.CO;2-F.
10
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.爱泼斯坦-巴尔病毒潜伏膜蛋白1恢复伯基特淋巴瘤细胞内源性抗原加工:肽转运体和HLA-I类抗原表达的协同上调
Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536.

引用本文的文献

1
HLA-transgenic mouse models to study autoimmune central nervous system diseases.用于研究自身免疫性中枢神经系统疾病的 HLA 转基因小鼠模型。
Autoimmunity. 2024 Dec;57(1):2387414. doi: 10.1080/08916934.2024.2387414. Epub 2024 Aug 21.
2
Identification and affinity enhancement of T-cell receptor targeting a KRAS cancer neoantigen.鉴定和增强针对 KRAS 癌症新抗原的 T 细胞受体的亲和力。
Commun Biol. 2024 Apr 29;7(1):512. doi: 10.1038/s42003-024-06209-2.
3
Vector-Mediated Delivery of Human Major Histocompatibility Complex-I into Hepatocytes Enables Investigation of T Cell Receptor-Redirected Hepatitis B Virus-Specific T Cells in Mice, and in Macaque Cell Cultures.

本文引用的文献

1
Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.人树突状细胞的长肽交叉呈递通过新生MHC I类分子上的肽交换在液泡中发生。
J Immunol. 2016 Feb 15;196(4):1711-20. doi: 10.4049/jimmunol.1501574. Epub 2016 Jan 20.
2
Surface expression, peptide repertoire, and thermostability of chicken class I molecules correlate with peptide transporter specificity.鸡I类分子的表面表达、肽库和热稳定性与肽转运体特异性相关。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):692-7. doi: 10.1073/pnas.1511859113. Epub 2015 Dec 22.
3
Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebrates.
载体介导的人主要组织相容性复合物-I 递送入肝细胞可在小鼠和食蟹猴细胞培养物中研究 T 细胞受体导向的乙型肝炎病毒特异性 T 细胞。
Hum Gene Ther. 2023 Dec;34(23-24):1204-1218. doi: 10.1089/hum.2023.035. Epub 2023 Dec 5.
4
Correlative CD4 and CD8 T-cell immunodominance in humans and mice: Implications for preclinical testing.人类和小鼠中相关的CD4和CD8 T细胞免疫显性:对临床前测试的意义。
Cell Mol Immunol. 2023 Nov;20(11):1328-1338. doi: 10.1038/s41423-023-01083-0. Epub 2023 Sep 19.
5
The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.雷公藤内酯醇对间充质基质细胞的免疫调节作用。
Front Immunol. 2021 Aug 16;12:686356. doi: 10.3389/fimmu.2021.686356. eCollection 2021.
6
Modeling pancreatic cancer in mice for experimental therapeutics.在小鼠中模拟胰腺癌用于实验治疗。
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188554. doi: 10.1016/j.bbcan.2021.188554. Epub 2021 May 1.
7
MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination.MYC 癌基因与肿瘤免疫抑制有关,靶向 Myc 可诱导肿瘤细胞免疫原性,用于治疗性全细胞疫苗接种。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001388.
8
Needle in a Haystack: The Naïve Repertoire as a Source of T Cell Receptors for Adoptive Therapy with Engineered T Cells.针锋相对:幼稚受体作为工程化 T 细胞过继免疫治疗中 T 细胞受体的来源。
Int J Mol Sci. 2020 Nov 6;21(21):8324. doi: 10.3390/ijms21218324.
9
Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy.抗原结构和组成设计以提高基于蛋白质的疫苗效力。
Front Immunol. 2020 Feb 24;11:283. doi: 10.3389/fimmu.2020.00283. eCollection 2020.
10
T Lymphocyte Development and Activation in Humanized Mouse Model.人源化小鼠模型中的T淋巴细胞发育与激活
Dev Reprod. 2019 Jun;23(2):79-92. doi: 10.12717/DR.2019.23.2.079. Epub 2019 Jun 30.
主要组织相容性复合体基因的共同进化(低分子量多肽/抗原加工相关转运体/Ⅰ类分子,自然杀伤T细胞-Ⅰ类b分子,自然杀伤细胞蛋白30-B7H6):来自冷血脊椎动物的启示
Immunol Rev. 2015 Sep;267(1):6-15. doi: 10.1111/imr.12324.
4
Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure.乙型肝炎病毒核心蛋白对 CD8(+) T 细胞选择压力的适应。
Hepatology. 2015 Jul;62(1):47-56. doi: 10.1002/hep.27771. Epub 2015 Mar 25.
5
The IPD and IMGT/HLA database: allele variant databases.国际参与者数据(IPD)和国际免疫遗传学信息系统/HLA数据库:等位基因变异数据库。
Nucleic Acids Res. 2015 Jan;43(Database issue):D423-31. doi: 10.1093/nar/gku1161. Epub 2014 Nov 20.
6
Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.人树突状细胞对合成长肽的交叉呈递:一个依赖于内质网相关蛋白降解(ERAD)组分p97/VCP而非Sec61和/或Derlin-1的过程。
PLoS One. 2014 Feb 27;9(2):e89897. doi: 10.1371/journal.pone.0089897. eCollection 2014.
7
An immunodominant HLA-A*1101-restricted CD8+ T-cell response targeting hepatitis B surface antigen in chronic hepatitis B patients.慢性乙型肝炎患者中针对乙型肝炎表面抗原的免疫优势 HLA-A*1101 限制性 CD8+ T 细胞反应。
J Gen Virol. 2013 Dec;94(Pt 12):2717-2723. doi: 10.1099/vir.0.052167-0. Epub 2013 Aug 30.
8
Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses.甲型流感病毒核蛋白是免疫优势 CD8+ T 细胞反应的主要靶标。
Immunol Cell Biol. 2013 Feb;91(2):184-94. doi: 10.1038/icb.2012.78.
9
The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?多肽疫苗治疗癌症的现状与未来:单一或多种、长肽或短肽、单独使用或联合使用?
Cancer J. 2011 Sep-Oct;17(5):343-50. doi: 10.1097/PPO.0b013e318233e5b2.
10
Retroviral transduction of T-cell receptors in mouse T-cells.小鼠T细胞中T细胞受体的逆转录病毒转导
J Vis Exp. 2010 Oct 22(44):2307. doi: 10.3791/2307.